SCHEMBL12820159

SCHEMBL12820159

Cc1c(F)cccc1[C@H](C)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.38
GABRA1 P14867 2/20 0.38
GABRG2 P18507 2/20 0.38
GABRB3 P28472 2/20 0.38
HTR2C P28335 2/20 0.38
FAAH O00519 1/20 0.38
CA1 P00915 1/20 0.38
CA2 P00918 1/20 0.38
LMNA P02545 1/20 0.38
CYP1A2 P05177 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
GABRB1 P18505 1/20 0.38
PTGS1 P23219 1/20 0.38
SLC6A2 P23975 1/20 0.38
GABRA5 P31644 1/20 0.38
GABRA3 P34903 1/20 0.38
HTR2B P41595 1/20 0.38
GABRA2 P47869 1/20 0.38
GABRB2 P47870 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20488788 1.00 CYP3A4 (0.38) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL30143789 1.00 CYP3A4 (0.38) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL6418653 0.84 TSHR (0.46) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL14530509 0.83 CES2 (0.36) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL765068 0.82 GABRA1 (0.46) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL23363630 0.80 CES2 (0.52) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL1993389 0.80 CES2 (0.52) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL29757453 0.80 CES2 (0.52) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL27904303 0.80 CES2 (0.52) CYP3A4GABRA1GABRG2GABRB3HTR2C
SCHEMBL30846991 0.80 CES2 (0.52) CYP3A4GABRA1GABRG2GABRB3HTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011032277-A1 QUINAZOLINONE DERIVATIVES AS VIRAL POLYMERASE INHIBITORS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-03-24 WO disclosed